贝伐单抗
医学
脑水肿
水肿
血管通透性
脑水肿
血管内皮生长因子
血脑屏障
肿瘤科
内科学
血管内皮生长因子受体
化疗
中枢神经系统
作者
Lan Yu,Xiaotao Zhang,Li Liu
出处
期刊:Journal of International Oncology
日期:2017-01-08
卷期号:44 (1): 41-44
标识
DOI:10.3760/cma.j.issn.1673-422x.2017.01.011
摘要
Anti-angiogenic drugs such as bevacizumab can effectively alleviate the patients′ brain edema and clinical symptoms and improve the patients′ life quality by reducing vascular permeability and the blood-brain barrier damage. Bevacizumab has got positive efficacy in the clinical, so that it is considered as an effective and safe treatment for malignant brain edema.
Key words:
Vascular endothelial growth factors; Brain edema; Brain neoplasms; Bevacizumab
科研通智能强力驱动
Strongly Powered by AbleSci AI